19-OCT-1987 14:30:56.94

SMITHKLINE <SKB> OPENS PLANT IN CHINA

SmithKline Beckman Corp said it opened an 8.5 mln dlr pharmaceutical manufacturing plant in Tianjin, China.     The plant will make pharmaceutical products for the joint venture company, Tianjin Smith Kline and French Laboratories.     SmithKline said the joint venture combines Smith Kline and French Laboratories, the pharmaceutical unit of SmithKline Beckman, the <Tianjin Medical Co>, and <Hebel Chemical Plant> in Tianjin.     The plant has the capability to produce one billion tablets and 200 mln capsules a year.  Reuter &#3;

